Frecuencia de deprescripción de medicamentos en pacientes que asisten a consulta externa de geriatría en un Hospital Universitario

dc.contributor.advisorAlfonso Hernández, Gladys
dc.contributor.authorLópez Guerrero, Vanessa
dc.contributor.authorDíaz Suárez, Lucia Cristina
dc.contributor.researchgroupGrupo de Apoyo Pedagógico y Formación Docente (GAPFD)spa
dc.coverage.countryColombia
dc.date.accessioned2023-09-04T19:48:42Z
dc.date.available2023-09-04T19:48:42Z
dc.date.issued2023-09-04
dc.descriptionilustraciones, diagramasspa
dc.description.abstractLa polifarmacia se ha asociado con incremento en la morbimortalidad y desenlaces adversos. El geriatra en este escenario realiza de forma sistemática el análisis para definir la pertinencia de continuar, modificar la dosis o sustituir un medicamento, teniendo en cuenta factores clínicos, farmacológicos y también las opiniones y preferencias del paciente; a este proceso se le denomina deprescripción. El objetivo del presente estudio fue identificar la frecuencia de deprescripción de medicamentos en la consulta de geriatría del HUN Métodos: Estudio descriptivo, observacional, retrospectivo. Se evaluaron historias clínicas de pacientes mayores de 60 años que asistieron por primera vez a la consulta externa de geriatría durante un periodo de 6 meses. Resultados: Se analizaron 426 historias clínicas. La edad promedio fue 83.4 años (DE 7.1). El 79.5% convivían con un cuidador familiar. Los síndromes geriátricos más frecuentes fueron fragilidad (75.4%) y trastorno neurocognitivo mayor (44.8%). Se encontró que el 56.6% tenían polifarmacia. La prevalencia de deprescripción fue de 68.3%. Los medicamentos más deprescritos fueron antihipertensivos no diuréticos (19.4%), estatinas (13.2%) y diuréticos (10.2%). Conclusiones: Se encontró una alta prevalencia de deprescripción. La fragilidad y el trastorno neurocognitivo mayor son motivos frecuentes de ajuste de metas de tratamiento que junto con la falta de indicación clínica, son los motivos más frecuentes de deprescripción. La deprescripción en el HUN está basada en la VGI y la aplicación de criterios implícitos. (Texto tomado de la fuente)spa
dc.description.abstractPolypharmacy has been associated with increased morbidity and mortality with adverse outcomes. The geriatrician in this scenario performs an analysis, in a systematic manner, to define the relevance of continuing or modifying the dose or replacing a drug taking into account clinical and pharmacological factors, as well as the opinions and preferences of the patient; this process is called deprescription. This study aims to determine the frequency of deprescription in the National University Hospital's Geriatric outpatient clinic. Methods: This was a descriptive, observational and retrospective study. Clinical records of patients aged 60 years and older, who attended the geriatric outpatient clinic of a university hospital over a 6-month period, were evaluated. Results: A total of 426 clinical records were analyzed. The mean age was 83.4 years (SD 7.1), and 79.5% lived with a family caregiver. The most frequent geriatric syndromes were frailty (75.4%) and major neurocognitive disorder (44.8%). It was found that 56.6% of patients had polypharmacy. The prevalence of medication deprescription was 68.3%. The most commonly deprescribed medications were non-diuretic antihypertensives (19.4%), statins (13.2%), and diuretics (10.2%). Conclusions: A high prevalence of medication deprescription was observed in this study. Frailty and major neurocognitive disorder were frequent reasons for treatment goal adjustments, which, along with the absence of clinical indication, were the most common reasons for deprescription. The deprescription process at HUN is based on the comprehensive geriatric assessment and the application of implicit criteria.eng
dc.description.degreelevelEspecialidades Médicasspa
dc.description.degreenameEspecialista en Geriatríaspa
dc.description.researchareaEvaluaciónspa
dc.format.extentiv, 84 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameUniversidad Nacional de Colombiaspa
dc.identifier.reponameRepositorio Institucional Universidad Nacional de Colombiaspa
dc.identifier.repourlhttps://repositorio.unal.edu.co/spa
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/84638
dc.language.isospaspa
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotáspa
dc.publisher.facultyFacultad de Medicinaspa
dc.publisher.placeBogotá, Colombiaspa
dc.publisher.programBogotá - Medicina - Especialidad en Geriatríaspa
dc.relation.referencesJordan, Joaquín; Garrido, Maria; Fernández I. Modificaciones farmacocinéticas y farmacodinámicas en el anciano. En: Abizanda Soler P, editor. Tratado de Medicina Geriátrica Fundamentos de la atención sanitaria a los mayores. 2a ed. Madrid; 2020. p. 72–8.spa
dc.relation.referencesHalli-Tierney AD, Scarbrough C, Carroll D. Polypharmacy: Evaluating risks and deprescribing. Am Fam Physician. el 1 de julio de 2019;100(1):32–8.spa
dc.relation.referencesRAE. No Title [Internet]. Diccionario de la lengua española. 2023. p. versión 23.6 en línea. Disponible en: https://dle.rae.es.spa
dc.relation.referencesPazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med [Internet]. 2021;12(3):443–52. Disponible en: https://doi.org/10.1007/s41999-021-00479-3.spa
dc.relation.referencesWastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185–96.spa
dc.relation.referencesSalud OMD La. Informe mundial definición polifarmacia. GINEBRA: OMS; 2013.spa
dc.relation.referencesScott IA, Hilmer SN, Reeve E, Potter K, Couteur D Le, Rigby D, et al. Reducing inappropriate polypharmacy: The process of deprescribing. JAMA Intern Med. 2015;175(5):827–34.spa
dc.relation.referencesScott IA, Anderson K, Freeman CR, Stowasser DA. First do no harm: A real need to deprescribe in older patients. Med J Aust. 2014;201(7):390–2.spa
dc.relation.referencesHovstadius B, Petersson G. Factors Leading to Excessive Polypharmacy. Clin Geriatr Med [Internet]. 2012;28(2):159–72. Disponible en: http://dx.doi.org/10.1016/j.cger.2012.01.001.spa
dc.relation.referencesOMS. Promoción del uso racional de medicamentos: componentes centrales. Perspect políticas sobre Medicam la OMS [Internet]. 2016;5:6. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/67532/WHO_EDM_2002.3_spa.pd f;jsessionid=D617F4B0991FF7D3766BA237F05506AB?sequence=1.spa
dc.relation.referencesMidão L, Giardini A, Menditto E, Kardas P, Costa E. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr [Internet]. 2018;78:213–20. Disponible en: https://doi.org/10.1016/j.archger.2018.06.018.spa
dc.relation.referencesMinisterio de Salud y Protección Social. Estudio nacional de salud, bienestar y envejecimiento (SABE) Colombia 2015. Resumen ejecutivo. Minsalud [Internet]. 2015;1:1–11. Disponible en: http://asuntosmayores.org/sitio/especiales/cifras/1188- comienza-sabe,-encuesta-sobre-condiciones-de-salud-y-bienestar-de-mayores-de 60-años.htm.spa
dc.relation.referencesCarrillo, Ana Julia; Portilla A. Polifarmacia en pacientes ambulatorios de 5 aseguradoras colombianas 2010-2014. En: Memorias VIII Encuentro Red Latinoamericana De Cuidado Al Paciente Crónico y La Familia. Bogotá: Universidad Nacional de Colombia; 2017. p. 15.spa
dc.relation.referencesRedston MR, Hilmer SN, McLachlan AJ, Clough AJ, Gnjidic D. Prevalence of Potentially Inappropriate Medication Use in Older Inpatients with and without Cognitive Impairment: A Systematic Review. J Alzheimers Dis. 2018;61(4):1639– 52.spa
dc.relation.referencesPravodelov V. Thoughtful Prescribing and Deprescribing. Med Clin North Am [Internet]. 2020;104(5):751–65. Disponible en: ttps://doi.org/10.1016/j.mcna.2020.06.001.spa
dc.relation.referencesConnor MNO, Gallagher P, Mahony DO. Inappropriate prescribing. N Z Med J. 2002;115(1146):28.spa
dc.relation.referencesO’Connor MN, Gallagher P, O’Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. junio de 2012;29(6):437–52.spa
dc.relation.referencesIe K, Aoshima S, Yabuki T, Albert SM. A narrative review of evidence to guide deprescribing among older adults. Vol. 22, Journal of General and Family Medicine. John Wiley and Sons Inc; 2021. p. 182–96.spa
dc.relation.referencesGnjidic D, Le Couteur DG, Hilmer SN. Discontinuing drug treatments: We need better evidence to guide deprescribing. BMJ. 2014;349(November):1–2.spa
dc.relation.referencesAbizanda Soler LRM. Fragilidad en el anciano. Tratado Med Geriátrica. 2020;2(71):671–87.spa
dc.relation.referencesHoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet [Internet]. 2019;394(10206):1365–75. Disponible en: http://dx.doi.org/10.1016/S0140- 6736(19)31786-6.spa
dc.relation.referencesRockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. C Can Med Assoc J. 2005;173(5):489–95.spa
dc.relation.referencesVan Kan GA, Rolland YM, Morley JE, Vellas B. Frailty: Toward a Clinical Definition. J Am Med Dir Assoc. 2008;9(2):71–2.spa
dc.relation.referencesHernández CZ. Definición de fragilidad social en personas mayores: una revisión bibliográfica. Rev Med Chil. 2020;148(12):1787–95.spa
dc.relation.referencesBunt S, Steverink N, Olthof J, van der Schans CP, Hobbelen JSM. Social frailty in older adults: a scoping review. Eur J Ageing. 2017;14(3):323–34.spa
dc.relation.referencesPalmer K, Villani ER, Vetrano DL, Cherubini A, Cruz-Jentoft AJ, Curtin D, et al. Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis. Eur Geriatr Med [Internet]. 2019;10(1):9–36. Disponible en: https://doi.org/10.1007/s41999-018-0124-5.spa
dc.relation.referencesHung C Di, Yang CC, Lee CY, Hu SCS, Chen SC, Hung CH, et al. Polypharmacy is significantly and positively associated with the frailty status assessed using the 5- item frail scale, cardiovascular health phenotypic classification of frailty index, and study of osteoporotic fractures scale. J Clin Med. 2021;10(19):4–13.spa
dc.relation.referencesLi Y, Zhang X, Yang L, Yang Y, Qiao G, Lu C, et al. Association between polypharmacy and mortality in the older adults: A systematic review and meta analysis. Arch Gerontol Geriatr. 2022;100:104630.spa
dc.relation.referencesRankin A, Cadogan CA, Patterson SM, Kerse N, Cardwell CR, Bradley MC, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane database Syst Rev. septiembre de 2018;9(9):CD008165.spa
dc.relation.referencesPark H-Y, Park J-W, Song HJ, Sohn HS, Kwon J-W. The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea. PLoS One. 2017;12(1):e0169463.spa
dc.relation.referencesNiikawa H, Okamura T, Ito K, Ura C, Miyamae F, Sakuma N, et al. Association between polypharmacy and cognitive impairment in an elderly Japanese population residing in an urban community. Geriatr Gerontol Int. septiembre de 2017;17(9):1286–93.spa
dc.relation.referencesRawle MJ, Cooper R, Kuh D, Richards M. Associations Between Polypharmacy and Cognitive and Physical Capability: A British Birth Cohort Study. J Am Geriatr Soc. mayo de 2018;66(5):916–23.spa
dc.relation.referencesPagán Núñez FT, Tejada Cifuentes F. Prescripción en Cascada y Desprescripción . Vol. 5, Revista Clínica de Medicina de Familia . scieloes ; 2012. p. 111–9.spa
dc.relation.referencesDelgado Silveira E, Montero Errasquín B, Muñoz García M, Vélez-Díaz-Pallarés M, Lozano Montoya I, Sánchez-Castellano C, et al. Mejorando la prescripción de medicamentos en las personas mayores: una nueva edición de los criterios STOPP-START. Rev Esp Geriatr Gerontol. 2015;50(2):89–96.spa
dc.relation.referencesMorales F, Martínez Á, Hernández P. Anamnesis, exploración física y pruebas complementarias en el anciano. Tratado Med Geriátrica. 2020;5:35–49.spa
dc.relation.referencesCristina Sanjoaquín Romero Elena Fernández Arín Ma Pilar Mesa Lampré Ernesto García-Arilla Calvo A. Capítulo 4 Valoración Geriátrica Integral. Tratado Geriatría para Resid [Internet]. 2004;1–10. Disponible en: https://www.segg.es/tratadogeriatria/PDF/S35-05 04_I.pdf.spa
dc.relation.referencesSanjoaquín C, Romero E, Fernández M, Mesa E CA. Capítulo 4 Valoración Geriátrica Integral. Tratado Geriatría para Resid. 2004;1–10.spa
dc.relation.referencesEmmanuel R, Junghanns A, Humberto C, Gil Z. Bases y dominios de la valoración geriátrica. Tratado Med geriátrica [Internet]. 2020;(1910):322–9. Disponible en: https://www.clinicalkey.es/#!/content/book/3-s2.0-B9788491132981000375.spa
dc.relation.referencesMontes JFG, Borrero CLC. Capacidad funcional en el anciano [Internet]. Salud del Anciano. Elsevier Espa8#241;a, S.L.; 2022. 191–200 p. Disponible en: http://dx.doi.org/10.1016/B978-84-9022-120-4/00021-5.spa
dc.relation.referencesCristofori G. Síndromes geriátricos: aspectos fisiopatológicos, clínicos y terapéuticos comunes. Vol. 2, Tratado de Medicina Geriátrica. 2021. 651–657 p.spa
dc.relation.referencesAbizanda Soler P, Sáez Méndez L, Cano C. Formación y docencia en Geriatría. Tratado Med Geriátrica [Internet]. 2015;80–93. Disponible en: http://dx.doi.org/10.1016/B978-84-9022-120-4/00011-2.spa
dc.relation.referencesReeve E, Thompson W, Farrell B. Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Eur J Intern Med [Internet]. 2017;38:3–11. Disponible en: http://dx.doi.org/10.1016/j.ejim.2016.12.021.spa
dc.relation.referencesReeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of “deprescribing” with network analysis: Implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–68.spa
dc.relation.referencesWoodward MC. Deprescribing: Achieving Better Health Outcomes for Older People Through Reducing Medications. J Pharm Pract Res. 2003;33(4):323–8.spa
dc.relation.referencesCouteur David Le, Gnjidic D, McLachlan A. Deprescribing. Aust Prescr [Internet]. 2011/12/01. 2011;34(6):182–5. Disponible en: https://www.nps.org.au/australian prescriber/articles/deprescribing.spa
dc.relation.referencesWilliams S, Miller G, Khoury R, Grossberg GT. Rational deprescribing in the elderly. Ann Clin psychiatry Off J Am Acad Clin Psychiatr. mayo de 2019;31(2):144–52.spa
dc.relation.referencesAmerican Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. abril de 2019;67(4):674–94.spa
dc.relation.referencesGallo C, Vilosio J, Saimovici J. Actualización de los criterios STOPP-START: una herramienta para la detección de medicación potencialmente inadecuada en ancianos New version of STOPP-START criteria: Tools for the detection of potentially inappropriate medications in the elderly. Actual en la Práctica Ambulatoria [Internet]. 2015;18(4):6. Disponible en: www.evidencia.org.ar.spa
dc.relation.referencesO’Mahony MS, Parbhoo A. Deprescribing in older people. Br J Hosp Med. 2020;81(1):114–20.spa
dc.relation.referencesRollet Q, Bouvier V, Moutel G, Launay L, Bignon AL, Bouhier-Leporrier K, et al. Multidisciplinary team meetings: are all patients presented and does it impact quality of care and survival – a registry-based study. BMC Health Serv Res. 2021;21(1):1–11.spa
dc.relation.referencesThio SL, Nam J, Van Driel ML, Dirven T, Blom JW. Effects of discontinuation of chronic medication in primary care: A systematic review of deprescribing trials. Br J Gen Pract. 2018;68(675):e663–72.spa
dc.relation.referencesMagin P, Quain D, Tapley A, van Driel M, Davey A, Holliday E, et al. Deprescribing in older patients by early-career general practitioners: Prevalence and associations. Int J Clin Pract [Internet]. el 1 de agosto de 2021 [citado el 6 de octubre de 2022];75(8). Disponible en: https://pubmed.ncbi.nlm.nih.gov/33960089.spa
dc.relation.referencesPotter K, Flicker L, Page A, Etherton-Beer C. Deprescribing in Frail Older People: A Randomised Controlled Trial. PLoS One. 2016;11(3):e0149984.spa
dc.relation.referencesGoyal P, Anderson TS, Bernacki GM, Marcum ZA, Orkaby AR, Kim D, et al. Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults. J Am Geriatr Soc. enero de 2020;68(1):78–86.spa
dc.relation.referencesZimmerman KM, Linsky AM. A narrative review of updates in deprescribing research. J Am Geriatr Soc. septiembre de 2021;69(9):2619–24.spa
dc.relation.referencesDjatche L, Lee S, Singer D, Hegarty SE, Lombardi M, Maio V. How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing? J Clin Pharm Ther. 2018;43(4):550–5.spa
dc.relation.referencesClough AJ, Hilmer SN, Kouladjian-O’Donnell L, Naismith SL, Gnjidic D. Health professionals’ and researchers’ opinions on conducting clinical deprescribing trials. Pharmacol Res Perspect. junio de 2019;7(3):e00476.spa
dc.relation.referencesBloomfield HE, Greer N, Linsky AM, Bolduc J, Naidl T, Vardeny O, et al. Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis. J Gen Intern Med. 2020;35(11):3323–32.spa
dc.relation.referencesCubillos Álzate JC, Matamoris Cárdenas, Mariana Perea Caro SA. Boletines Poblacionales: Personas Adultas Mayores de 60 años. Minsalud - Gob Colomb [Internet]. 2020;10. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/PS/boletines poblacionales-envejecimiento.pdf.spa
dc.relation.referencesHarris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform [Internet]. 2019;95(May):103208. Disponible en: https://doi.org/10.1016/j.jbi.2019.103208.spa
dc.relation.referencesLindley D V. STATISTICS AS A MATHEMATICAL DISCIPLINE BY PREPARED UNDER GRANT DAAG29-77-G-0031 FOR THE U . S . ARMY RESEARCH OFFICE Reproduction in Whole or in Part is Permitted for any purpose of the United States Government Approved for public release ; distribution . 1979;(33).spa
dc.relation.referencesRStudio Team. RStudio: Integrated Development Environment for R [Internet]. Boston, MA; 2015. [Internet]. 2015. Disponible en: http://www.rstudio.com.spa
dc.relation.referencesHarris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform [Internet]. 2009;42(2):377–81. Disponible en: http://dx.doi.org/10.1016/j.jbi.2008.08.010.spa
dc.relation.referencesEsteban Jiménez Ó, Arroyo Aniés MP, Vicens Caldentey C, González Rubio F, Hernández Rodríguez MÁ, Sempere Manuel M. Deprescribing to increase people health or when deprescribing could be the best pill. Aten Primaria [Internet]. 2018;50:70–9. Disponible en: https://doi.org/10.1016/j.aprim.2018.09.001.spa
dc.relation.referencesSong E, Ouellette CP, Reeve E. Deprescribing. UpToDate. 2022;1–69.spa
dc.relation.referencesDavid E, Bautista G. Costos de la deprescripción de medicamentos en adultos mayores. Repositorio Universidad Nacional de Colombia. 2023.spa
dc.relation.referencesCano-Guitierrez C, Samper-Ternent R, Cabrera J, Rosselli D. Medication use among older adults in Bogota, Colombia. Rev Peru Med Exp Salud Publica. 2016;33(3):419–24.spa
dc.relation.referencesBaldoni A de O, Ayres LR, Martinez EZ, Dewulf N de LS, Dos Santos V, Pereira LRL. Factors associated with potentially inappropriate medications use by the elderly according to Beers criteria 2003 and 2012. Int J Clin Pharm. abril de 2014;36(2):316–24.spa
dc.relation.referencesReeve J, Maden M, Hill R, Turk A, Mahtani K, Wong G, et al. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis. Health Technol Assess (Rockv). 2022;26(32):VII–108.spa
dc.relation.referencesStahl V. Deprescribing. Med Monatsschr Pharm. 2021;44(12):465–71.spa
dc.relation.referencesGarcía-Peña ÁA, Ospina D, Rico J, Fernández-ávila DG, Muñoz-Velandia Ó, Suárez-Obando F. Prevalence of arterial hypertension in Colombia according to data from the Comprehensive Social Protection Information System (SISPRO). Rev Colomb Cardiol. 2022;29(1):29–35.spa
dc.relation.referencesOliveros E, Patel H, Kyung S, Fugar S, Goldberg A, Madan N, et al. Hypertension in older adults: Assessment, management, and challenges. Clin Cardiol. febrero de 2020;43(2):99–107.spa
dc.relation.referencesGuerrero A. Patrón social del deterioro cognitivo en Colombia. Repos UniAndes. 2015;151(16):10–7.spa
dc.relation.referencesScott IA, Hilmer SN, Le Couteur DG. Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older Patients. Drugs Aging. agosto de 2019;36(8):675–85.spa
dc.relation.referencesSheppard JP, Benetos A, McManus RJ. Antihypertensive Deprescribing in Older Adults: a Practical Guide. Curr Hypertens Rep [Internet]. 2022;24(11):571–80. Disponible en: https://doi.org/10.1007/s11906-022-01215-3.spa
dc.relation.referencesAlbasri A, Hattle M, Koshiaris C, Dunnigan A, Paxton B, Fox SE, et al. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis. BMJ. febrero de 2021;372:n189.spa
dc.relation.referencesCorrao G, Mazzola P, Monzio Compagnoni M, Rea F, Merlino L, Annoni G, et al. Antihypertensive Medications, Loop Diuretics, and Risk of Hip Fracture in the Elderly: A Population-Based Cohort Study of 81,617 Italian Patients Newly Treated Between 2005 and 2009. Drugs Aging. noviembre de 2015;32(11):927–36.spa
dc.relation.referencesHorodinschi R-N, Stanescu AMA, Bratu OG, Pantea Stoian A, Radavoi DG, Diaconu CC. Treatment with Statins in Elderly Patients. Medicina (Kaunas). octubre de 2019;55(11).spa
dc.relation.referencesKutner JS, Blatchford PJ, Taylor DH, Ritchie CS, Bull JH, Fairclough DL, et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life limiting illness a randomized clinical trial. JAMA Intern Med. 2015;175(5):691–700.spa
dc.relation.referencesElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 13. Older Adults: Standards of Care in Diabetes—2023. Diabetes Care [Internet]. el 12 de diciembre de 2022;46(Supplement_1):S216–29. Disponible en: https://doi.org/10.2337/dc23-S013.spa
dc.relation.referencesMurillo Muñoz M. Potenciales omisiones en la prescripción médica en una muestra de pacientes Colombianos con riesgo cardiovascular [Internet]. Universidad Nacional de Colombia Sede Bogotá Facultad de Ciencias Departamento de Farmacia. 2016. Disponible en: https://repositorio.unal.edu.co/handle/unal/58239.spa
dc.relation.referencesMakizako H, Shimada H, Doi T, Tsutsumimoto K, Hotta R, Nakakubo S, et al. Social frailty leads to the development of physical frailty among physically non-frail adults: A four-year follow-up longitudinal cohort study. Int J Environ Res Public Health. 2018;15(3).spa
dc.relation.referencesMantell R, Hwang YIJ, Radford K, Perkovic S, Cullen P, Withall A. Accelerated aging in people experiencing homelessness: A rapid review of frailty prevalence and determinants. Front public Heal. 2023;11:1086215.spa
dc.relation.referencesMehrabi F, Béland F. Effects of social isolation, loneliness and frailty on health outcomes and their possible mediators and moderators in community-dwelling older adults: A scoping review. Arch Gerontol Geriatr. 2020;90:104119.spa
dc.relation.referencesMinisterio de Salud y Protección Social. Resolución No. 84-30 de 1993 (octubre 4). 1993.spa
dc.relation.referencesPauff SM, Miller SC. The Medication Appropriateness Index at 20: Where it Started, Where it has been and Where it May be Going. Bone [Internet]. 2012;78(2):711–6. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624763/pdf/nihms412728.pdfspa
dc.relation.referencesChang TI, Park H, Kim DW, Jeon EK, Rhee CM, Kalantar-Zadeh K, et al. Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study. Sci Rep [Internet]. 2020;10(1):1–9. Disponible en: https://doi.org/10.1038/s41598-020-75888-8.spa
dc.relation.referencesLee EA, Brettler JW, Kanter MH, Steinberg SG, Khang P, Distasio CC, et al. Refining the Definition of Polypharmacy and Its Link to Disability in Older Adults: Conceptualizing Necessary Polypharmacy, Unnecessary Polypharmacy, and Polypharmacy of Unclear Benefit. Perm J. 2020;24:1–6.spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.licenseAtribución-NoComercial-SinDerivadas 4.0 Internacionalspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.subject.ddc610 - Medicina y salud::618 - Ginecología, obstetricia, pediatría, geriatríaspa
dc.subject.decsServicios de salud para ancianosspa
dc.subject.decsHealth Services for the Agedeng
dc.subject.decsDrug Prescriptionseng
dc.subject.decsPrescripciones de medicamentosspa
dc.subject.proposalDeprescripciónspa
dc.subject.proposalDeprescriptioneng
dc.subject.proposalPolifarmaciaspa
dc.subject.proposalPolypharmacyeng
dc.subject.proposalAdulto mayorspa
dc.subject.proposalElderlyeng
dc.subject.proposalGeriatríaspa
dc.subject.proposalGeriatricseng
dc.titleFrecuencia de deprescripción de medicamentos en pacientes que asisten a consulta externa de geriatría en un Hospital Universitariospa
dc.title.translatedFrequency of medication deprescription in geriatric outpatient Clinic of a University Hospitaleng
dc.typeTrabajo de grado - Especialidad Médicaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdccspa
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/masterThesisspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TMspa
dc.type.versioninfo:eu-repo/semantics/acceptedVersionspa
dcterms.audience.professionaldevelopmentPúblico generalspa
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2spa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
46386566.2023.pdf
Tamaño:
1.03 MB
Formato:
Adobe Portable Document Format
Descripción:
Trabajo de grado Especialidad en Geriatría

Bloque de licencias

Mostrando 1 - 2 de 2
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
5.74 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Cargando...
Miniatura
Nombre:
U.FT.09.006.004 Licencia para publicación de obras en el Repositorio Institucional UNAL v4.pdf
Tamaño:
217.38 KB
Formato:
Adobe Portable Document Format
Descripción: